OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Recent advances in hepatocellular carcinoma therapeutic strategies and imaging-guided treatment
Yan Du, Di Liu, Yong‐Zhong Du
Journal of drug targeting (2021) Vol. 30, Iss. 3, pp. 287-301
Closed Access | Times Cited: 8
Yan Du, Di Liu, Yong‐Zhong Du
Journal of drug targeting (2021) Vol. 30, Iss. 3, pp. 287-301
Closed Access | Times Cited: 8
Showing 8 citing articles:
Angelica Sinensis Polysaccharide-Based Nanoparticles for Liver-Targeted Delivery of Oridonin
Henglai Sun, Jijuan Nai, Biqi Deng, et al.
Molecules (2024) Vol. 29, Iss. 3, pp. 731-731
Open Access | Times Cited: 10
Henglai Sun, Jijuan Nai, Biqi Deng, et al.
Molecules (2024) Vol. 29, Iss. 3, pp. 731-731
Open Access | Times Cited: 10
Scutellaria baicalensis Induces Cell Apoptosis and Elicits Mesenchymal–Epithelial Transition to Alleviate Metastatic Hepatocellular Carcinoma via Modulating HSP90β
Tung-Ho Wu, Tung-Yi Lin, Pei‐Ming Yang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 3073-3073
Open Access | Times Cited: 3
Tung-Ho Wu, Tung-Yi Lin, Pei‐Ming Yang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 3073-3073
Open Access | Times Cited: 3
Composite Nanoplatforms Based on Nanocalcium Peroxide for Cancer Treatment: From Monotherapy to Combination Therapy
Xinze Hu, Jiale Liu, Yuxin Wang, et al.
Advanced Therapeutics (2023) Vol. 6, Iss. 8
Closed Access | Times Cited: 6
Xinze Hu, Jiale Liu, Yuxin Wang, et al.
Advanced Therapeutics (2023) Vol. 6, Iss. 8
Closed Access | Times Cited: 6
Comparison of effectiveness and safety of camrelizumab between HBV-related and non-B, non-C hepatocellular carcinoma: A retrospective study in China
Haonan Liu, Xiaobing Qin, Zhiyuan Xu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 9
Haonan Liu, Xiaobing Qin, Zhiyuan Xu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 9
Single low-dose INC280-loaded theranostic nanoparticles achieve multirooted delivery for MET-targeted primary and liver metastatic NSCLC
Yige Sun, Jie Yang, Yingbo Li, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Yige Sun, Jie Yang, Yingbo Li, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Development and optimization of a self micro-emulsifying drug delivery system (SMEDDS) for co-administration of sorafenib and curcumin
Xingzhen Huang, Lizhen Feng, Xuefang Lu, et al.
Drug Delivery and Translational Research (2024)
Closed Access | Times Cited: 1
Xingzhen Huang, Lizhen Feng, Xuefang Lu, et al.
Drug Delivery and Translational Research (2024)
Closed Access | Times Cited: 1
Unravelling the role of natural and synthetic products as DNA topoisomerase inhibitors in hepatocellular carcinoma
Qing Ren, Guoming Chen, Qi Wan, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107860-107860
Closed Access | Times Cited: 1
Qing Ren, Guoming Chen, Qi Wan, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107860-107860
Closed Access | Times Cited: 1
Multifunctional Drug-Loaded Phase-Change Nanoparticles Inhibit the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Affecting the Activity of Activated Hepatic Stellate Cells
Xiaomeng Zou, Tiantian Li, Yingxuan Mao, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-18
Open Access | Times Cited: 1
Xiaomeng Zou, Tiantian Li, Yingxuan Mao, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-18
Open Access | Times Cited: 1
